Douglas G. McNeel

Also affiliated with University of Wisconsin Carbone Cancer Center

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 32 papers. Top paper: “Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer”.

Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0945

N/A

1.6DataRank · unranked

64 citations

Jens C. Eickhoff, Anna C. Ferrari, Michael T. Schweizer, Ellen Wargowski, Brian M. Olson +2 more

Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004198

N/A

1.2DataRank · unranked

52 citations

Jens C. Eickhoff, Ellen Wargowski, Laura E. Johnson, Christos E. Kyriakopoulos, Hamid Emamekhoo +4 more

Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-008067

N/A

0.937DataRank · unranked

36 citations

Hamid Emamekhoo, Jens C. Eickhoff, Christos E. Kyriakopoulos, Ellen Wargowski, Tommaso P Tonelli +3 more

Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004191

N/A

0.655DataRank · unranked

78 citations

Anne‐Gaëlle Goubet, Kousuke Ueda, Andrew Maltez Thomas, Valentin Quiniou, Cassandra Thélémaque +32 more

Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Cancers(2020)10.3390/cancers12102831

N/A

0.510DataRank · unranked

29 citations

Donghwan Jeon, Laura E. Johnson, Jena E. Moseman, Anusha Muralidhar, Hemanth K. Potluri +5 more

Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001510

N/A

0.464DataRank · unranked

21 citations

Tun Lee Ng, Michael A. Newton, Jin Zhang, Christopher A. Maher, Peter S. Nelson +2 more

Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer

Human Vaccines & Immunotherapeutics(2024)10.1080/21645515.2024.2395680

N/A

0.408DataRank · unranked

10 citations

Jens C. Eickhoff, Laura E. Johnson, Glenn Liu, Douglas G. McNeel, Tommaso P Tonelli

Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008848

N/A

0.373DataRank · unranked

11 citations

Melissa Gamat, Sita Vakkalanka, Douglas G. McNeel, Anusha Muralidhar

Immunomodulatory effects of alpha vs beta radiopharmaceutical therapy in murine prostate cancer

Frontiers in Immunology(2025)10.3389/fimmu.2025.1563387

N/A

0.345DataRank · unranked

9 citations

Hemanth K. Potluri, Mojdeh Mahmoudian, Christopher F. Massey, Joseph J. Grudzinski, Amanda Carston +15 more

Reversible Epigenetic Alterations Regulate Class I HLA Loss in Prostate Cancer

Research Square(2021)10.21203/rs.3.rs-894353/v1

N/A

0.292DataRank · unranked

6 citations

Erika Henninger, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Kristin N. Carlson, Madison Kircher +8 more

Profound immunomodulatory effects of 225 Ac-NM600 drive enhanced anti-tumor response in prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.26.509374

N/A

0.269DataRank · unranked

3 citations

Hemanth K. Potluri, Christopher Massey, Joseph J. Grudzinski, Amanda Carston, Nathan C. Clemons +12 more

Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer

Vaccines(2025)10.3390/vaccines13090976

N/A

0.241DataRank · unranked

4 citations

Daeun Shim, Donghwan Jeon, Ichwaku Rastogi, Kaitlyn M. Schneider, Douglas G. McNeel +1 more

β-amino acid substitution in the SIINFEKL antigen alters immunological recognition

Cancer Biology & Therapy(2025)10.1080/15384047.2025.2486141

N/A

0.241DataRank · unranked

4 citations

John A. Mannone, Ruslan Gibadullin, Jena E. Moseman, John Sidney, A Sette +3 more

Prostate tumor immune microenvironment changes following immunotherapy shared by patients who developed anti-tumor response or immune-related adverse events

OncoImmunology(2025)10.1080/2162402x.2025.2595788

N/A

0.208DataRank · unranked

3 citations

Douglas G. McNeel, Ichwaku Rastogi

Evaluation of agents that affect anti-tumor function of CD8 + T cells when employed at the time of T-cell activation

Methods in cell biology(2025)10.1016/bs.mcb.2025.02.016

N/A

0.104DataRank · unranked

1 citations

Jena E. Moseman, Donghwan Jeon, Anusha Muralidhar, Douglas G. McNeel, Ichwaku Rastogi

CD8+ T Cells Primed by Antigenic Peptide-Pulsed B Cells or Dendritic Cells Generate Similar Anti-Tumor Response

Vaccines(2025)10.3390/vaccines13090953

N/A

0DataRank · unranked

0 citations

Wanyi Guo, Jena E. Moseman, Douglas G. McNeel, Ichwaku Rastogi

Spatial proteomic analysis reveals vaccine and PD-1 blockade elicits changes to the prostate tumor immune microenvironment with infiltration of dendritic cells and activated CD8 T cells 2502

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.412

N/A

0DataRank · unranked

0 citations

Douglas G. McNeel, Ichwaku Rastogi

Toll like receptor agonist effects on human CD8+ T cell activation and expression of T cell checkpoint receptors

Human Vaccines & Immunotherapeutics(2025)10.1080/21645515.2025.2598694

N/A

0DataRank · unranked

0 citations

Jena E. Moseman, Ethan C. Hill, Douglas G. McNeel, Donghwan Jeon

Phase II trial of a DNA vaccine encoding prostatic acid phosphatase (pTVG-HP) and nivolumab (Nivo) in patients (pts) with nonmetastatic, PSA-recurrent prostate cancer (PCa).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.tps273

N/A

0DataRank · unranked

2 citations

Christos E. Kyriakopoulos, Glenn Liu, Douglas G. McNeel, Hamid Emamekhoo

Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice

The Journal of Immunology(2021)10.4049/jimmunol.2000656

N/A

0DataRank · unranked

4 citations

Manasi Mohan, Ravi B. Patel, Jen Birstler, Lauren Nettenstrom, Dagna Sheerar +11 more

Role of B cells as antigen presenting cells

Frontiers in Immunology(2022)10.3389/fimmu.2022.954936

N/A

0DataRank · unranked

328 citations

Donghwan Jeon, Jena E. Moseman, Anusha Muralidhar, Hemanth K. Potluri, Douglas G. McNeel +1 more

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

Communications Biology(2022)10.1038/s42003-022-03843-6

N/A

0DataRank · unranked

52 citations

Erika Héninger, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Kristin N. Carlson, Madison Kircher +8 more

Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005060

N/A

0DataRank · unranked

32 citations

Carolina A. Ferreira, Joseph J. Grudzinski, Christopher Massey, Eduardo Aluicio‐Sarduy, Jonathan W. Engle +7 more

Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression

OncoImmunology(2022)10.1080/2162402x.2022.2054758

N/A

0DataRank · unranked

20 citations

Douglas G. McNeel, Donghwan Jeon

870 High-dose radiation is required for effective combination with tumor-specific vaccination in a prostate cancer model

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0870

N/A

0DataRank · unranked

0 citations

Carolina A. Ferreira, Joseph J. Grudzinski, Christopher F. Massey, Reinier Hernandez, Jamey P. Weichert +2 more

Toll-like receptor agonists as cancer vaccine adjuvants

Human Vaccines & Immunotherapeutics(2023)10.1080/21645515.2023.2297453

N/A

0DataRank · unranked

50 citations

Ethan C. Hill, Douglas G. McNeel, Donghwan Jeon

Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer

Pharmaceutics(2023)10.3390/pharmaceutics15010252

N/A

0DataRank · unranked

14 citations

Hemanth K. Potluri, Tanya Jaiswal, Douglas G. McNeel, Anusha Muralidhar

B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA

OncoImmunology(2023)10.1080/2162402x.2023.2212550

N/A

0DataRank · unranked

7 citations

Douglas G. McNeel, Ichwaku Rastogi

Data from Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T Cells

(2023)10.1158/2326-6066.c.6548576.v1

N/A

0DataRank · unranked

0 citations

Melissa Gamat, Joseph Seliski, Thomas Sawicki, Justin J. Jeffery, Leigh Ellis +4 more

Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008799

N/A

0DataRank · unranked

22 citations

Ethan C. Hill, Jena E. Moseman, Douglas G. McNeel, Donghwan Jeon

Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using 90Y-NM600 in combination with androgen deprivation therapy in murine prostate tumors

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008760

N/A

0DataRank · unranked

11 citations

Reinier Hernandez, Zachary S. Morris, Hansel Comas Rojas, Malick Bio Idrissou, Jamey P. Weichert +2 more

Hydroxyapatite Binding Peptide Lipid Nanoparticles for Biomimetic mRNA Delivery to Bone

Advanced Therapeutics(2025)10.1002/adtp.202400505

N/A

0DataRank · unranked

2 citations

Jena E. Moseman, Jamie Jones, Jacobus C. Burger, Ashley M. Weichmann, Douglas G. McNeel +2 more